Pre-conditioning with transcranial low-level light therapy reduces neuroinflammation and protects blood-brain barrier after focal cerebral ischemia in mice
Restricted accessResearch articleFirst published online March 21, 2016
Pre-conditioning with transcranial low-level light therapy reduces neuroinflammation and protects blood-brain barrier after focal cerebral ischemia in mice
Purpose: Transcranial low-level light therapy (LLLT) has gained interest as a non-invasive, inexpensive and safe method of modulating neurological and psychological functions in recent years. This study was designed to examine the preventive effects of LLLT via visible light source against cerebral ischemia at the behavioral, structural and neurochemical levels.
Methods: The mice received LLLT twice a day for 2 days prior to photothrombotic cortical ischemia.
Results: LLLT significantly reduced infarct size and edema and improved neurological and motor function 24 h after ischemic injury. In addition, LLLT markedly inhibited Iba-1- and GFAP-positive cells, which was accompanied by a reduction in the expression of inflammatory mediators and inhibition of MAPK activation and NF-κB translocation in the ischemic cortex. Concomitantly, LLLT significantly attenuated leukocyte accumulation and infiltration into the infarct perifocal region. LLLT also prevented BBB disruption after ischemic events, as indicated by a reduction of Evans blue leakage and water content. These findings were corroborated by immunofluorescence staining of the tight junction-related proteins in the ischemic cortex in response to LLLT.
Conclusions: Non-invasive intervention of LLLT in ischemic brain injury may provide a significant functional benefit with an underlying mechanism possibly being suppression of neuroinflammation and reduction of BBB disruption.
AgrawalT., GuptaG.K., RaiV., CarrollJ.D., & HamblinM.R. (2014). Pre-conditioning with low-level laser (light) therapy: Light before the storm. Journal of International Dose-Response Society, 12, 619–649.
BorlonganC.V., GloverL.E., SanbergP.R., & HessD.C. (2012). Permeating the blood brain barrier and abrogating the inflammation in stroke: Implications for stroke therapy. Current Pharmaceutical Design, 18, 3670–3676.
4.
ChoiD.H., LeeK.H., KimJ.H., KimM.Y., LimJ.H., & LeeJ. (2012a). Effect of 710nm visible light irradiation on neurite outgrowth in primary rat cortical neurons following ischemic insult. Biochemical and Biophysical Research Communications, 422, 274–279.
5.
ChoiD.H., LimJ.H., LeeK.H., KimM.Y., KimH.Y., ShinC.Y., HanS.H., & LeeJ. (2012b). Effect of 710-nm visible light irradiation on neuroprotection and immune function after stroke. Neuroimmunomodulation, 19, 267–276.
6.
ChungH., DaiT., SharmaS.K., HuangY.Y., CarrollJ.D., & HamblinM.R. (2012). The nuts and bolts of low-level laser (light) therapy. Annals of Biomedical Engineering, 40, 516–533.
7.
del ZoppoG.J., MilnerR., MabuchiT., HungS., WangX., BergG.I., & KoziolJ.A. (2007). Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke, 38, 646–651.
8.
DetaboadaL., IlicS., Leichliter-MarthaS., OronU., OronA., & StreeterJ. (2006). Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers in Surgery and Medicine, 38, 70–73.
9.
EmsleyH.C., & TyrrellP.J. (2002). Inflammation and infection in clinical stroke. Journal of Cerebral Blood Flow and Metabolism, 22, 1399–1419.
10.
GesueteR., KohamaS.G., & Stenzel-PooreM.P. (2014). Toll-like receptors and ischemic brain injury. Journal of Neuropathology & Experimental Neurology, 73, 378–386.
11.
GiddayJ.M., GascheY.G., CopinJ.C., ShahA.R., PerezR.S., ShapiroS.D., ChanP.H., & ParkT.S. (2005). Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. H. American Journal of Physiology Heart and Circulatory Physiology, 289, 558–568.
12.
GorinaR., Font-NievesM., Marquez-KisinouskyL., SantaluciaT., & PlanasA.M. (2011). Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak/Stat pathways. Glia, 59, 242–255.
13.
JacobsA.H., TavitianB., & consortiumI.N. (2012). Noninvasive molecular imaging of neuroinflammation. Journal of Cerebral Blood Flow and Metabolism, 32, 1393–1415.
14.
JungW.K., AhnY.W., LeeS.H., ChoiY.H., KimS.K., YeaS.S., ChoiI., ParkS.G., SeoS.K., LeeS.W., & ChoiI.W. (2009). Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways. Food and Chemical Toxicology, 47, 410–417.
15.
KhumanJ., ZhangJ., ParkJ., CarrollJ.D., DonahueC., & WhalenM.J. (2012). Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice. Journal of Neurotrauma, 29, 408–417.
16.
KimS.H., SmithC.J., & Van EldikL.J. (2004). Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiology of Aging, 25, 431–439.
17.
KirkJ., PlumbJ., MirakhurM., & McQuaidS. (2003). Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. Journal of Pathology, 201, 319–327.
18.
LamplY., ZivinJ.A., FisherM., LewR., WelinL., DahlofB., BorensteinP., AnderssonB., PerezJ., CaparoC., IlicS., & OronU. (2007). Infrared laser therapy for ischemic stroke: A new treatment strategy: Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke, 38, 1843–1849.
19.
LapchakP.A., SalgadoK.F., ChaoC.H., & ZivinJ.A. (2007). Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: An extended therapeutic window study using continuous and pulse frequency delivery modes. Neuroscience, 148, 907–914.
LeungM.C., LoS.C., SiuF.K., & SoK.F. (2002). Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor-beta 1. Lasers in Surgery and Medicine, 31, 283–288.
23.
LiX., BlizzardK.K., ZengZ., DeVriesA.C., HurnP.D., & McCulloughL.D. (2004). Chronic behavioral testing after focal ischemia in the mouse: Functional recovery and the effects of gender. Experimental Neurology, 187, 94–104.
24.
MichalikovaS., EnnaceurA., van RensburgR., & ChazotP.L. (2008). Emotional responses and memory performance of middle-aged CD1 mice in a 3D maze: Effects of low infrared light. Neurobiology of Learning Memory, 89, 480–488.
25.
MoreiraM.S., VelascoI.T., FerreiraL.S., ArigaS.K., BarbeiroD.F., MeneguzzoD.T., AbatepauloF., & MarquesM.M. (2009). Effect of phototherapy with low intensity laser on local and systemic immunomodulation following focal brain damage in rat. Journal of Photochemistry and Photobiology B, 97, 145–151.
26.
MoroC., TorresN., El MassriN., RatelD., JohnstoneD.M., StoneJ., MitrofanisJ., & BenabidA.L. (2013). Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: Evidence from two mouse strains. BMC Neuroscience, 14, 40.
27.
NaeserM.A., SaltmarcheA., KrengelM.H., HamblinM.R., & KnightJ.A. (2011). Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: Two case reports. Photomedicine and Laser Surgery, 29, 351–358.
28.
OhtsukiS., & TerasakiT. (2007). Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharmaceutical Research, 24, 1745–1758.
29.
QuirkB.J., TorbeyM., BuchmannE., VermaS., & WhelanH.T. (2012). Near-infrared photobiomodulation in an animal model of traumatic brain injury: Improvements at the behavioral and biochemical levels. Photomedicine and Laser Surgery, 30, 523–529.
30.
RizziC.F., MaurizJ.L., Freitas CorreaD.S., MoreiraA.J., ZettlerC.G., FilippinL.I., MarroniN.P., & González-GallegoJ. (2006). Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle. Lasers in Surgery Medicine, 38, 704–713.
RojasJ.C., & Gonzalez-LimaF. (2013). Neurological and psychological applications of transcranial lasers and LEDs. Biochemical Pharmacology, 86, 447–457.
33.
SchifferF., JohnstonA.L., RavichandranC., PolcariA., TeicherM.H., WebbR.H., & HamblinM.R. (2009). Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: A pilot study of 10 patients with major depression and anxiety. Behavioral and Brain Functions, 5, 46.
34.
StaglianoN.E., Perez-PinzonM.A., MoskowitzM.A., & HuangP.L. (1999). Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. Journal of Cerebral Blood Flow and Metabolism, 19, 757–761.
35.
TuX.K., YangW.Z., ShiS.S., WangC.H., ZhangG.L., NiT.R., ChenC.W., WangR., JiaJ.W., & SongQ.M. (2010). Spatio-temporal distribution of inflammatory reaction and expression of TLR2/4 signaling pathway in rat brain following permanent focal cerebral ischemia. Neurochemical Research, 35, 1147–1155.
36.
WangQ., TangX.N., & YenariM.A. (2007). The inflammatory response in stroke. Journal of Neuroimmunology, 184, 53–68.
37.
ZhaoC.S., PuurunenK., SchallertT., SiveniusJ., & JolkkonenJ. (2005). Behoral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behavioural Brain Research, 158, 211–220.
